U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Hypertrophic cardiomyopathy 6

Summary

Mutations in the PRKAG2 gene (602743) give rise to a moderate, essentially heart-specific, nonlysosomal glycogenosis with clinical onset typically in late adolescence or in the third decade of life, ventricular pre-excitation predisposing to supraventricular arrhythmias, mild to severe cardiac hypertrophy, enhanced risk of sudden cardiac death in midlife, and autosomal dominant inheritance with full penetrance (summary by Burwinkel et al., 2005). [from OMIM]

Genes See tests for all associated and related genes

  • Also known as: AAKG, AAKG2, CMH6, H91620p, WPWS, PRKAG2
    Summary: protein kinase AMP-activated non-catalytic subunit gamma 2

Clinical features

Help

Show allHide all

Practice guidelines

  • EuroGenetest, 2011
    Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14).

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.